On October 1, 2025, Bausch Health voluntarily withdrew from both the 340B Drug Pricing Program and the Medicaid Drug Rebate Program (MDRP). This action applies to 12 labeler codes and …
340B
BPHC Issues Updated NOA Terms for 330(e) Grantees
HRSA announced new requirements related to the April 15th 2025 Executive Order. Health centers participating in 340B and receiving 330(e) funding must provide insulins and injectable epinephrine at 340B discounts …
The Sanofi Rebate Model – December 2, 2024 Webinar Presentation
On December 2, 2024 Draffin Tucker offered a 340B Webinar for CHCs reviewing the new Sanofi rebate model. Below is the link to the PowerPoint presentation. Draffin Tucker Client Webinar …
HRSA’s Office of Pharmacy Affairs initiates Hospital Integrity Checks for 340B Hospitals
HRSA audit findings related to incorrect OPAIS records have increased in the last few audit cycles. In response, HRSA appears to be initiating a new “Integrity Check” to validate the …
Upcoming 340B Webinar Offering for CHCs
For over 30 years, covered entities have accessed 340B discounts in the form of an upfront discount on the purchase price of drugs through their wholesaler or distributor. In August, …
340B Recertification for Hospitals
340B Recertification for Hospitals began on August 12, 2024, and must be completed by September 9, 2024. The annual 340B recertification is underway and provides an opportunity for a comprehensive …
Novo Nordisk expands 340B contract pharmacy restrictions
Novo Nordisk expands 340B contract pharmacy restrictions to all covered entity types and modifies its hospital policy. On May 1, 2024, the drug manufacturer Novo Nordisk posted a notice outlining …
340B Recertification
340B Recertification for Community Health Centers begins February 1, 2021 and must be completed by March 1. The annual 340B recertification provides an opportunity for a comprehensive review of your …